Tibsovo Price | Best Ivosidenib 250 mg Generic

0.00$

Attribute Details
Brand Name Tibsovo
Generic Name Ivosidenib
Drug Class IDH1 inhibitor
Uses Treatment of acute myeloid leukemia (AML) with IDH1 mutation, cholangiocarcinoma with IDH1 mutation, and other IDH1-mutant cancers.
Manufacturer Agios Pharmaceuticals (now part of Servier)
Approval FDA-approved for AML and cholangiocarcinoma
Dosage Form Oral tablets (250 mg)
Administration Taken orally, typically once daily
Side Effects Common side effects include nausea, diarrhea, fatigue, and differentiation syndrome.
Special Instructions Can be taken with or without food; avoid high-fat meals.
Add to wishlist
Share

    Tibsovo Price: Get Authentic Generic Tibsovo 250mg at a Reasonable Rate

    Introduction of Tibsovo 

    Tibsovo (ivosidenib) 250mg is a targeted cancer therapy used to treat certain cancers with IDH1 mutations, including acute myeloid leukemia (AML) and cholangiocarcinoma (bile duct cancer). Ivosidenib inhibits the mutated IDH1 enzyme, slowing cancer cell growth. Tibsovo is taken orally, typically 500 mg once daily. Assistance programs are available to help with cost, and it’s FDA-approved for its specific indications.

    What is Tibsovo (Ivosidenib)?

    Tibsovo, the brand name for ivosidenib 250mg, inhibits mutant isocitrate dehydrogenase-1 (IDH1), an enzyme often mutated in cancers. By targeting this enzyme, Tibsovo slows cancer growth in cells relying on the mutated enzyme for survival.

    FDA Approval and Indications

    FDA Approval: Tibsovo (Ivosidenib) was approved by the FDA in July 2018 for treating acute myeloid leukemia (AML) with an IDH1 mutation.

    Indications:

    Cholangiocarcinoma: Tibsovo treats cholangiocarcinoma (bile duct cancer) with IDH1 mutations.

    Acute Myeloid Leukemia (AML): Used in AML patients with the IDH1 mutation.

    Astrocytoma: Currently under study for treating brain tumors like astrocytoma.

     

    Cholangiocarcinoma: Provides a targeted therapy for patients with IDH1 mutations.

    AML: Effectively addresses AML by targeting its underlying genetic mutation.

    Astrocytoma & Brain Cancer: Research is ongoing to evaluate its effectiveness in treating brain tumors.

    Dosage and Administration Tibsovo (Ivosidenib):

    Tibsovo (Ivosidenib) is typically administered as an oral tablet, with a recommended dose of 500 mg daily.

    Dosage may vary, so always follow your specialist advice.

     

    Side Effects of Tibsovo (Ivosidenib) 250mg

    Common Side Effects:

    Nausea

    Diarrhea

    Decreased appetite

    Vomiting

    Serious Side Effects:

    Differentiation syndrome (rapid cancer cell differentiation)

    Liver issues (elevated liver enzymes).

    Copay Card and Assistance Programs: Tibsovo offers copay assistance and patient support to ease financial burdens for eligible patients.

    Availability in Different Countries:

    Australia: Approved for specific uses.

    Canada: Available through healthcare channels.

    Manufacturer and Distribution

    Agios Pharmaceuticals produce Tibsovo (Ivosidenib), in partnership with Servier for distribution. It’s available via specialized pharmacies and healthcare providers.

    Research and Clinical Trials

    Ongoing trials are investigating Tibsovo’s potential in other cancers and its use in combination with other therapies.

    Regulatory and Safety Information

    FDA and EMA Approvals: Tibsovo (Ivosidenib) 250mg is FDA- and EMA-approved for its specific uses, based on rigorous trials.

    Safety and Monitoring: Regular health assessments, including liver function tests, are recommended.

    Patient Assistance and Support

    Copay Assistance Programs: Financial aid for eligible patients.

    Patient Assistance Program: Offers medication access and financial help.

    Comparison with Other Medications

    Tibsovo (Ivosidenib) 250mg is compared with other IDH inhibitors for efficacy, side effects, and patient outcomes. Always consult with your doctor for the best treatment choice.

    Conclusion

    Tibsovo (Ivosidenib) is a cutting-edge cancer therapy that targets IDH1 mutations. By understanding its uses, side effects, and costs, patients can make informed treatment decisions.

     

    FAQs

    What is Tibsovo used for?

    Tibsovo 250mg treats cancers with IDH1 mutations, such as AML, cholangiocarcinoma, and possibly brain tumors.

    Does Tibsovo (Ivosidenib) have side effects?

    Common side effects include nausea, fatigue, and diarrhea. Serious effects may involve liver issues and differentiation syndrome.

    Is there a generic version of Tibsovo (Ivosenib) ?

    Yes, Tibsovo (Ivosidenib) is available in a generic form at a lower cost.

    How can I access Tibsovo (Ivosidenib) assistance programs?

    Tibsovo offers copay and patient assistance programs.

    Tibsovo price : Tibsovo price is depend much expensive. Generic Tibsovo is available at best price.

     

    Buy Tibsovo Online

    Tibsovo Purchase

    Tibsovo Order

    Tibsovo for Sale

     

    Tibsovo Cost

    Tibsovo Price

     

    Tibsovo 250 mg Tablet Price

    Tibsovo Discount

    Tibsovo Copay Card

    Tibsovo Patient Assistance

    Tibsovo Prescription

    Tibsovo Drug Cost

    Order Tibsovo Online

    Tibsovo USA Price

    Tibsovo Canada Price

    Tibsovo Australia Cost

    Tibsovo Payment Options

    4o